The latest price target for HilleVax (NASDAQ:HLVX) was reported by HC Wainwright & Co. on August 12, 2024. The analyst firm set a price target for $2.00 expecting HLVX to rise to within 12 months (a possible 6.95% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for HilleVax (NASDAQ:HLVX) was provided by HC Wainwright & Co., and HilleVax reiterated their neutral rating.

There is no last upgrade for HilleVax

The last downgrade for HilleVax Inc happened on July 9, 2024 when Leerink Partners changed their price target from $28 to $2 for HilleVax Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HilleVax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HilleVax was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

While ratings are subjective and will change, the latest HilleVax (HLVX) rating was a reiterated with a price target of $2.00 to $2.00. The current price HilleVax (HLVX) is trading at is $1.87, which is out of the analyst’s predicted range.